Proper application of Natroba™

Keys to successfully terminating the lice cycle:

  1. Use as much product as needed to completely cover the scalp first, and then apply outwards towards the ends of the hair.
  2. For very thick, medium length hair or long hair, an entire bottle (120 mL) of Natroba™ Topical Suspension may be needed to cover the scalp and hair. Less Natroba™ Topical Suspension may be needed for shorter, thinner hair.
  3. One week (7 days) after first treatment, if live lice are seen, repeat the treatment.

An easy 1-, 2-, 3-step approach for properly applying Natroba™ Topical Suspension.

Important: For topical use only on scalp and scalp hair. Do not get Natroba™ Topical Suspension in eyes, mouth, or vagina.

Adjunctive measures

Natroba™ Topical Suspension should be used in the context of an overall lice management program:

• Wash (in hot water) or dry clean all recently worn clothing, hats, used bedding and towels
• Wash personal care items such as combs, brushes, and hair clips in hot water
• A fine-toothed comb or special nit comb may be used to remove dead lice and nits.

Reference:

Natroba Prescribing Information.

NAT-RRW11-000

Indication
Natroba™ Topical Suspension is a pediculicide indicated for the topical treatment of head lice infestations in patients six (6) months of age and older.

Adjunctive Measures
Natroba™ Topical Suspension should be used in the context of an overall lice management program:

Important Safety Information

Indication
Natroba™ Topical Suspension is a pediculicide indicated for the topical treatment of head lice infestations in patients six (6) months of age and older.

Adjunctive Measures
Natroba™ Topical Suspension should be used in the context of an overall lice management program:
• Wash (in hot water) or dry clean all recently worn clothing, hats, used bedding and towels
• Wash personal care items such as combs, brushes, and hair clips in hot water
• A fine-toothed comb or special nit comb may be used to remove dead lice and nits.

Important Safety Information
Natroba™ Topical Suspension contains benzyl alcohol and is not recommended for use in neonates and infants below the age of 6 months. Systemic exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants when administered intravenously. Most common adverse events were: application site redness (3%), eye redness (2%) and application site irritation (1%).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.